AAM
Advisors Asset Management Portfolio holdings
AUM
$5.59B
1-Year Return
19.2%
This Quarter Return
-8.31%
1 Year Return
+19.2%
3 Year Return
+63.25%
5 Year Return
+116.36%
10 Year Return
+228.02%
AUM
$6.27B
AUM Growth
-$1.02B
(-14%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-3.97%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
1,944
New
111
Increased
642
Reduced
1,061
Closed
60
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$11.9M |
| 2 |
CenterPoint Energy
CNP
|
+$6.1M |
| 3 |
CIM
Chimera Investment
CIM
|
+$5.77M |
| 4 |
PPL Corp
PPL
|
+$5.73M |
| 5 |
PMT
PennyMac Mortgage Investment
PMT
|
+$5.73M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
+$20.7M |
| 2 |
Eli Lilly
LLY
|
+$14M |
| 3 |
UIL
UIL HOLDINGS
UIL
|
+$13.6M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$13.1M |
| 5 |
Darden Restaurants
DRI
|
+$12.5M |
Sector Composition
| 1 | Healthcare | 10.42% |
| 2 | Energy | 8.35% |
| 3 | Financials | 7.74% |
| 4 | Industrials | 7.11% |
| 5 | Technology | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Thomson Reuters
TRI
$78.1B
| $5.87M | 0.09% |
127,657
+1,285
| +1% | +$59.1K |
|
302
Helmerich & Payne
HP
$2.05B
| $5.83M | 0.09% |
123,313
-9,465
| -7% | -$447K |
|
|
ALXN
303
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.77M | 0.09% |
36,892
-2,846
| -7% | -$445K |
|
304
Enterprise Products Partners
EPD
$69B
| $5.76M | 0.09% |
231,370
-9,971
| -4% | -$248K |
|
305
Nike
NKE
$110B
| $5.75M | 0.09% |
93,466
+52,960
| +131% | +$3.26M |
|
|
NS
306
DELISTED
NuStar Energy L.P.
NS
| $5.68M | 0.09% |
126,625
-1,112
| -0.9% | -$49.8K |
|
307
Cracker Barrel
CBRL
$1.12B
| $5.62M | 0.09% |
38,169
-4,699
| -11% | -$692K |
|
308
Kellanova
K
$27.6B
| $5.62M | 0.09% |
89,953
-5,662
| -6% | -$354K |
|
309
Kayne Anderson Energy Infrastructure Fund
KYN
$2.08B
| $5.6M | 0.09% |
241,398
-12,381
| -5% | -$287K |
|
310
Pediatrix Medical
MD
$1.46B
| $5.58M | 0.09% |
72,717
+10,539
| +17% | +$809K |
|
|
PMO
311
Putnam Municipal Opportunities Trust
PMO
$286M
| $5.53M | 0.09% |
462,239
-121,125
| -21% | -$1.45M |
|
312
Invesco High Income Trust II
VLT
$73.2M
| $5.5M | 0.09% |
427,103
+51,358
| +14% | +$661K |
|
313
UnitedHealth
UNH
$312B
| $5.48M | 0.09% |
47,266
+30,839
| +188% | +$3.58M |
|
314
Lennox International
LII
$19.9B
| $5.46M | 0.09% |
48,177
+4,194
| +10% | +$475K |
|
315
Bausch Health
BHC
$2.69B
| $5.44M | 0.09% |
30,477
-1,754
| -5% | -$313K |
|
316
Danaher
DHR
$141B
| $5.44M | 0.09% |
94,925
-4,010
| -4% | -$230K |
|
|
NPI
317
DELISTED
NUVEEN PREMIUN INC MUN FUND
NPI
| $5.43M | 0.09% |
405,282
-99,105
| -20% | -$1.33M |
|
318
Fidus Investment
FDUS
$757M
| $5.42M | 0.09% |
393,495
-73,607
| -16% | -$1.01M |
|
319
Jazz Pharmaceuticals
JAZZ
$7.75B
| $5.42M | 0.09% |
40,829
-217
| -0.5% | -$28.8K |
|
320
TechnipFMC
FTI
$16.8B
| $5.41M | 0.09% |
234,509
+5,182
| +2% | +$120K |
|
321
Consolidated Edison
ED
$34.9B
| $5.4M | 0.09% |
80,748
-4,129
| -5% | -$276K |
|
322
Novo Nordisk
NVO
$244B
| $5.4M | 0.09% |
198,922
+5,168
| +3% | +$140K |
|
|
ORAN
323
DELISTED
Orange
ORAN
| $5.39M | 0.09% |
356,709
-29,533
| -8% | -$447K |
|
324
Matrix Service
MTRX
$351M
| $5.39M | 0.09% |
239,958
-23,342
| -9% | -$525K |
|
|
NMO
325
DELISTED
NUVEEN MUNI MARKET OPPORT FUND
NMO
| $5.39M | 0.09% |
411,610
+27,441
| +7% | +$359K |
|